{
    "clinical_study": {
        "@rank": "136140", 
        "arm_group": [
            {
                "arm_group_label": "V.A.C.Ulta with instillation", 
                "arm_group_type": "Experimental", 
                "description": "Treatment Arm"
            }, 
            {
                "arm_group_label": "V.A.C.Ulta without instillation", 
                "arm_group_type": "Active Comparator", 
                "description": "Control Arm"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to examine the effectiveness of the V.A.C.Ulta Negative\n      Pressure Wound Therapy System and V.A.C. VeraFlo Dressing System in wounds that require\n      operative debridement."
        }, 
        "brief_title": "A Prospective, Multi-Center Trial Evaluating the Effectiveness of the V.A.C. Ulta Negative Pressure Wound Therapy System With V.A.C. VeraFlo Dressing System in Operatively Debrided Wounds", 
        "completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Wounds and Injuries", 
        "condition_browse": {
            "mesh_term": "Wounds and Injuries"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        The Subject:\n\n          -  will be admitted as an inpatient\n\n          -  is >= 18 years of age at time of consent\n\n          -  is able to provide his/her own informed consent\n\n          -  is willing and able to return for all scheduled and required study visits\n\n          -  has an open wound >= 4cm in any plane of measurement excluding tunnels\n\n          -  has a wound that is appropriate for NPWT according to approved indications for use\n\n          -  has not participated in a clinical trial within the past 30 days\n\n          -  has a 30 day wound history available if the wound has been previously treated\n\n        Exclusion Criteria:\n\n        The Subject:\n\n          -  is pregnant as determined by a positive serum or urine pregnancy test at the time of\n             screening\n\n          -  has a life expectancy of < 12 months\n\n          -  is not healthy enough to undergo surgery for any reason\n\n          -  has, in the investigator's opinion, any clinically significant condition that would\n             impair the participant's ability to comply with the study procedures\n\n          -  has, in the opinion of the investigator, a condition that will not allow the subject\n             to tolerate the therapy (e.g. painful conditions such as vasculitis)\n\n          -  has rheumatoid arthritis\n\n          -  has a bleeding disorder or coagulopathy\n\n          -  has a wound that contains antibiotic cement or beads\n\n          -  has an ischemic lower extremity wound as determined by lack of detectable pulses in\n             the extremity or ankle-brachial pressure indices of < 0.9 with a history of diabetes,\n             or < 0.6 if the subject is non-diabetic\n\n          -  has a known allergy or hypersensitivity to V.A.C. Therapy dressing components\n             including polyurethane or polyvinyl alcohol (drape and foam), or materials that\n             contain acrylic adhesive (drape adhesive)\n\n          -  has a known allergy or hyper sensitivity to 3M Cavilon No Sting Barrier Film or any\n             of its components including Hexamethyldisiloxane, isooctane, acrylate terpolymer,\n             polyphenylmethysiloxane, copolymer\n\n          -  has a know allergy or hypersensitivity to Prontosan or any of its components\n             including polyhexamethylene biguanide (PHMB), or undecylenamidopropyl betaine\n\n          -  has received NPWT on the study wound within the last 30 days\n\n          -  has a wound that is contraindicated with Prontosan\n\n             a. presence of hyaline cartilage in the wound\n\n          -  has a wound that is contraindicated with V.A.C. Therapy including:\n\n               1. malignancy in the wound\n\n               2. untreated osteomyelitis\n\n               3. non-enteric or unexplored fistulas\n\n               4. necrotic tissue with eschar remaining in the wound after debridement (NOTE: Once\n                  necrotic tissue or eschar is removed from the wound bed, subjects may be\n                  included)\n\n               5. unprotected, exposed blood vessels, anastomotic sites, organs, or nerves in\n                  direct contact with foam\n\n          -  use of intervening layers between the wound bed and foam\n\n          -  has a wound that is contraindicated with V.A.C. VeraFlo Therapy including:\n\n               1. Thoracic or abdominal cavities\n\n               2. Unexplored wounds that may communicate with adjacent body cavities\n\n          -  has a wound that is closed after the initial debridement"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01867580", 
            "org_study_id": "AHS.2011.ULTA.04"
        }, 
        "intervention": [
            {
                "arm_group_label": "V.A.C.Ulta with instillation", 
                "description": "NPWT with instillation of a wound cleanser", 
                "intervention_name": "V.A.C.Ulta with instillation", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "V.A.C.Ulta without instillation", 
                "description": "NPWT only", 
                "intervention_name": "V.A.C.Ulta without instillation", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 26, 2013", 
        "location": [
            {
                "contact": {
                    "last_name": "Zinnia Rocha", 
                    "phone": "202-444-0793"
                }, 
                "facility": {
                    "address": {
                        "city": "Washington DC", 
                        "country": "United States", 
                        "state": "District of Columbia", 
                        "zip": "20007"
                    }, 
                    "name": "Medstar Georgetown University Hospital"
                }, 
                "investigator": {
                    "last_name": "Christopher Attinger, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "kpiserch@nmh.org", 
                    "last_name": "Katherine Piserchia", 
                    "phone": "312-695-5233"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "Northwestern University"
                }, 
                "investigator": {
                    "last_name": "Robert D Galiano, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ejhughes@partners.org", 
                    "last_name": "Elizabeth J Hughes", 
                    "phone": "617-732-7874"
                }, 
                "contact_backup": {
                    "email": "lbayer@partners.org", 
                    "last_name": "Lauren R Bayer, PA", 
                    "phone": "617-732-8743"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Brigham and Women's Hospital"
                }, 
                "investigator": {
                    "last_name": "Dennis P Orgill, MD, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "renee.davis@utsouthwestern.edu", 
                    "last_name": "Renee Davis, BSN, RN", 
                    "phone": "214-648-5687"
                }, 
                "contact_backup": {
                    "email": "deanna.adams@utsouthwestern.edu", 
                    "last_name": "Deanna S Adams, RN", 
                    "phone": "214-645-8907"
                }, 
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75390"
                    }, 
                    "name": "University of Texas Southwestern"
                }, 
                "investigator": {
                    "last_name": "Lawrence Lavery, DPM", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Randomized, Multi-Center Trial Evaluating the Effectiveness of the V.A.C. Ulta Negative Pressure Wound Therapy System With V.A.C. VeraFlo Dressing System in Operatively Debrided Wounds", 
        "overall_contact": {
            "email": "anthony.tate@kci1.com", 
            "last_name": "Anthony C Tate, BSN, RN", 
            "phone": "210-515-4060"
        }, 
        "overall_contact_backup": {
            "email": "jill.twardowski@kci1.com", 
            "last_name": "Jill S Twardowski, BSN, RN", 
            "phone": "210-515-4166"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Institutional Review Board", 
                "United States: Data and Safety Monitoring Board", 
                "United States: Food and Drug Administration"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of Operative Debridements", 
            "safety_issue": "No", 
            "time_frame": "until the wound is deemed ready for closure or coverage by the investigator up to 64 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01867580"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "KCI USA, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "KCI USA, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}